Excited to share this call for papers for a special issue that I am editing with two colleagues, focusing on Reproductive Health! Please consider submitting a manuscript and share this call to anyone who might be interested! 🤓
link.springer.com/journal/42…
Can I now claim expertise about Cuffing Season (i.e.,seasonality in looking for romantic/sexual partners)?!
In all seriousness, glad I could contribute to this informative podcast!
(Also, seems like there’s evidence for cuffing season based on activity in online dating apps)
PFRH's @alisongemmill guests on the latest episode of @voxdotcom's Explain It to Me podcast, providing scientific context to help answer the question: Is Cuffing Season real? Snuggle up and listen now: podcasts.apple.com/us/podcas…
#APACC2025#AsiaPacific in Japan next year! Excellent opportunity to contribute to HIV research and discussion in the Asia-Pacific region. Abstract submission Deadline:Â 7 March 2025, 23:59 JST. Submit Here: amededu.co/3A40Cj5@Academic_MedEdu
Key findings from @ICW_Global & @UNAIDS confronting coercion report, all happening within the last year of coercive practices across 23 countries hearing from over 25,000 women
Don't miss doctoral candidate Ying (Sally) Zhang's poster on a global review of national guidelines of post-exposure prophylaxis for the prevention of HIV, presented by @DrJasonJOng, today at #AIDS2024 and online.
@MonashSTM@MonashResearch@Alfred_Research
In the PURPOSE 1 randomized, controlled trial involving women in South Africa & Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection. Full trial results: nej.md/3zRElVj#AIDS2024
ALT Bar chart of background HIV incidence and HIV incidence in lenacapavir, F/TAF, and F/TDF groups.
📊 Today at #AIDS2024, Past IAS President @LindaGailBekker presents full results from PURPOSE 1 trial. The results confirm #lenacapavir demonstrated 100% efficacy for #HIV prevention in cisgender women.
Read IAS President & AIDS 2024 Int'l Co-Chair @ProfSharonLewin's statement.
Apply now for a scholarship to attend the APACC 2023, Asian Stigma & Discrimination Forum, and HIV Cascade of Care. Deadline: 30 April 2023. @annettesohnBKK@IHRIOfficial
Details>> bit.ly/43ynnG5
📣 @jiasociety is publishing a new supplement in 2024 on “Implementation research and the #HIV response” and is looking for abstracts.
âś… Learn more now and submit your abstract by 15 May! bit.ly/3Zb5dY2
Showcase your incredible work in HIV/sexual health at #APACC2023, whether it be research, practice, or community engagement! Late-breaker submission will open soon on April 3. Both structured abstracts ("research") and descriptive abstracts ("lessons learned") are welcome!